In patients with sickle cell disease, Hb in the relaxed state (oxygenated) seems to be less vulnerable to sickling and therefore left‐shifting the ODC is discussed as a therapeutic target (Nakagawa et al., 2014). The gene discussed is GSTM1; the disease is sickle cell disease.